4.7 Letter

Stereotactic Body Radiation Therapy for Liver Tumors In Regard to Kim et al. and Ohri et al. Reply

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Oncology

Stereotactic Body Radiation Therapy for Liver Tumors In Regard to Kim et al. and Ohri et al.

Yuichiro Tsurugai et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Oncology

Local Control After Stereotactic Body Radiation for Liver Tumors

Pelvis Nitin Ohri et al.

Summary: The study evaluated local control rates after SBRT for primary and metastatic liver tumors. Results showed high rates of durable local control for primary liver tumors with no clear dose-response relationship, while better outcomes were observed for liver metastases treated with higher BEDs.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study

Nalee Kim et al.

Summary: This study found that the prescribed radiation dose level of SBRT is significantly associated with treatment outcomes in hepatocellular carcinoma patients, with patients in the BED >= 100 Gy group showing better rates of local tumor control and overall survival. Additionally, a dose-response relationship was observed between FFLP and BED.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview

Jimm Grimm et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)